AI-assisted written information to support treatment for chronic anal fissure
Official title: Effect of AI-Assisted Written Patient Information on Medical Treatment Adherence and Short-Term Patient-Reported Outcomes in Primary Chronic Anal Fissure: A Prospective Randomized Controlled Trial
Run by Sanliurfa Education and Research Hospital · NCT07701811 · Data updated 2026-11-12
This trial compares AI-assisted written information to standard verbal counseling to see if people with a chronic anal fissure better stick with initial medical treatment.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 220 (estimated) |
| Sponsor | Sanliurfa Education and Research Hospital Government |
| Locations | 1 site (Sanliurfa) |
| Status | Recruiting |
| Started | July 15, 2026 |
| Main results expected | December 31, 2026 |
| Study ends | December 31, 2026 |
| Registry record updated | September 9, 2026 |
| Trial ID | NCT07701811 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18 and older with primary chronic anal fissure planned for initial medical/conservative treatment who can read Turkish and are reachable by telephone.
✕Probably not a fit
Patients who are not comfortable with written information or who have factors that limit adherence despite information delivery may see no benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This is a single-center, prospective, randomized trial in adults with primary chronic anal fissure starting conservative treatment. Participants are randomized 1:1 to receive either standard verbal counseling or AI-assisted written information covering the same medical content. The study measures complete treatment adherence at day 14 as the primary endpoint, with secondary outcomes including pain, PGI-C, quality of life (HEMO-FISS-QoL), stool form, additional health visits, need for interventional treatment, and patient satisfaction. Assessments occur at baseline, by phone on days 7 and 14, and in person at week 6. The intervention and control differ only by the information delivery method; the medical treatment is identical across groups.
Why it matters
Potential benefit: If successful, AI-assisted written information could improve treatment adherence and patient experience during Conservative treatment for chronic anal fissure.
How similar studies have gone: Prior work suggests tailored information delivery can influence adherence in some conditions, but this specific AI-assisted, written-information approach for anal fissure is novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 years or older 2. Clinical diagnosis of primary chronic anal fissure 3. Initial medical/conservative treatment planned at first evaluation 4. Ability to read and understand Turkish 5. Reachable by telephone 6. Provision of written informed consent Exclusion Criteria: 1. Acute anal fissure 2. Suspicion or diagnosis of secondary fissure (including Crohn's disease, tuberculosis, HIV-related lesion, suspected malignancy, or atypical lateral fissure) 3. Planned botulinum toxin, surgery, or another interventional treatment 4. History of botulinum toxin or surgical treatment for anal fissure within the last 6 months 5. Concomitant perianal abscess, fistula, advanced hemorrhoidal disease, or another significant anorectal pathology 6. Pregnancy and early postpartum period
Where it's running
-
Sanliurfa Education and Research Hospital
Sanliurfa, Turkey (Türkiye) Recruiting
Study contacts
- Study coordinator: Vedat Kaplan
- Email: vedat_kaplan_@hotmail.com
- Phone: +905459045165
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Three LIS techniques for chronic anal fissure healing
This trial tests three different ways of performing lateral internal sphincterotomy to see which best heals chronic anal fissures with the least risk of incontinence.
-
Combined surgical approach for chronic anal fissure
This trial tries removing the fissure and giving botulinum toxin A to relax the internal anal sphincter in people with chronic anal fissure to reduce pain, recurrence, and sphincter problems.
-
Treatment for chronic anal fissures using E-CEL UVEC cells
This study is testing if injections of special cells can help people with chronic anal fissures who haven't found relief from regular treatments.
-
Ultrasound-based look at how much sphincter is cut during LIS for chronic anal fissure
This study tests whether the amount of internal anal sphincter divided during lateral internal sphincterotomy affects healing and continence in adults with chronic anal fissure.
-
Botox injections alone vs with fissurectomy and anoplasty for chronic anal fissure
This study tests whether adding fissurectomy and anoplasty to Botox injections helps healing and pain relief for adults with chronic anal fissure.
-
Improving recovery after surgery for benign anorectal conditions
This study is testing if a special recovery plan can help people aged 18 to 65 have fewer problems with urinary retention after surgery for conditions like hemorrhoids and anal fissures.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.